Why AJILE?
AJILE= Pilot study to assess clinical impact of new 6Fr AngioJet Xpeedior for treating patients with limb-threatening clot in leg arteries/bypass grafts; either stand-alone, or in combination with lytics.
treatment success (immediate, long term)
complications (amputation, mortality)
Principal Investigator: Ted Chambers, MD